carbamates has been researched along with Cryoglobulinemia in 9 studies
Cryoglobulinemia: A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After a median follow-up period of 26 months (interquartile range, 20-30 mo), no patients had a serious adverse event or relapse of vasculitis." | 5.46 | Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis. ( Alric, L; Bouyer, AS; Cacoub, P; Comarmond, C; de Saint Martin, L; Ferfar, Y; Hezode, C; Musset, L; Pol, S; Poynard, T; Resche Rigon, M; Saadoun, D; Si Ahmed, SN, 2017) |
| "We conducted an observational prospective study, on 232 patients with chronic kidney disease, undergoing treatment with paritaprevir/ombitasvir/ritonavir and dasabuvir, for chronic hepatitis C infection - genotype 1b." | 3.96 | Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. ( Iliescu, EL; Mercan-Stanciu, A; Toma, L, 2020) |
| " After a median follow-up period of 26 months (interquartile range, 20-30 mo), no patients had a serious adverse event or relapse of vasculitis." | 1.46 | Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis. ( Alric, L; Bouyer, AS; Cacoub, P; Comarmond, C; de Saint Martin, L; Ferfar, Y; Hezode, C; Musset, L; Pol, S; Poynard, T; Resche Rigon, M; Saadoun, D; Si Ahmed, SN, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Iliescu, EL | 1 |
| Mercan-Stanciu, A | 1 |
| Toma, L | 1 |
| Shimada, M | 1 |
| Nakamura, N | 1 |
| Endo, T | 1 |
| Yamabe, H | 1 |
| Nakamura, M | 1 |
| Murakami, R | 1 |
| Narita, I | 1 |
| Tomita, H | 1 |
| Sankhyan, P | 1 |
| Gonzalez-Estrada, A | 1 |
| Boglione, L | 1 |
| Cusato, J | 1 |
| Pinna, SM | 1 |
| De Nicolò, A | 1 |
| Cariti, G | 1 |
| Di Perri, G | 1 |
| D'Avolio, A | 1 |
| Kuwano, T | 1 |
| Akuta, N | 1 |
| Suzuki, F | 1 |
| Fujiyama, S | 1 |
| Kawamura, Y | 1 |
| Sezaki, H | 1 |
| Hosaka, T | 1 |
| Saitoh, S | 1 |
| Kobayashi, M | 2 |
| Suzuki, Y | 1 |
| Arase, Y | 1 |
| Ikeda, K | 1 |
| Kumada, H | 1 |
| Elmowafy, AY | 1 |
| El Maghrabi, HM | 1 |
| Zahab, MA | 1 |
| Elwasif, SM | 1 |
| Bakr, MA | 1 |
| Gragnani, L | 1 |
| Piluso, A | 1 |
| Urraro, T | 1 |
| Fabbrizzi, A | 1 |
| Fognani, E | 1 |
| Petraccia, L | 1 |
| Genovesi, A | 1 |
| Giubilei, L | 1 |
| Ranieri, J | 1 |
| Stasi, C | 1 |
| Monti, M | 1 |
| Zignego, AL | 1 |
| Comarmond, C | 2 |
| Garrido, M | 1 |
| Pol, S | 2 |
| Desbois, AC | 1 |
| Costopoulos, M | 1 |
| Le Garff-Tavernier, M | 1 |
| Si Ahmed, SN | 2 |
| Alric, L | 2 |
| Fontaine, H | 1 |
| Bellier, B | 1 |
| Maciejewski, A | 1 |
| Rosenzwajg, M | 1 |
| Klatzmann, D | 1 |
| Musset, L | 2 |
| Poynard, T | 2 |
| Cacoub, P | 2 |
| Saadoun, D | 2 |
| Ferfar, Y | 1 |
| Hezode, C | 1 |
| de Saint Martin, L | 1 |
| Bouyer, AS | 1 |
| Resche Rigon, M | 1 |
2 reviews available for carbamates and Cryoglobulinemia
| Article | Year |
|---|---|
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
Topics: Aged; Antiviral Agents; Carbamates; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferat | 2017 |
Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
Topics: Aged; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Female; Hepacivirus; | 2017 |
7 other studies available for carbamates and Cryoglobulinemia
| Article | Year |
|---|---|
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Drug Thera | 2020 |
Mixed Essential Cryoglobulinemia.
Topics: Antiviral Agents; Carbamates; Cryoglobulinemia; Exanthema; Hepatitis C; Heterocyclic Compounds, 4 or | 2017 |
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Dru | 2018 |
A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis.
Topics: Aged; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Female; Hepatitis C, | 2018 |
Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
Topics: Antiviral Agents; Carbamates; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephriti | 2018 |
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Topics: Aged; Antiviral Agents; B-Lymphocyte Subsets; Biomarkers; Carbamates; Case-Control Studies; Cryoglob | 2017 |
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Topics: Antiviral Agents; B-Lymphocytes; Carbamates; CD4-Positive T-Lymphocytes; Cryoglobulinemia; Cryoglobu | 2017 |